Literature DB >> 12878494

Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Gerhard F Weldhagen1, Laurent Poirel, Patrice Nordmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12878494      PMCID： PMC166056          DOI： 10.1128/AAC.47.8.2385-2392.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  54 in total

1.  Extended-spectrum β-lactamase TEM-4 in Pseudomonas aeruginosa.

Authors:  L Poirel; E Ronco; T Naas; P Nordmann
Journal:  Clin Microbiol Infect       Date:  1999-10       Impact factor: 8.067

2.  Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Authors:  F Luzzaro; E Mantengoli; M Perilli; G Lombardi; V Orlandi; A Orsatti; G Amicosante; G M Rossolini; A Toniolo
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.

Authors:  L B Rice; J D Yao; K Klimm; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 4.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

Authors:  A A Medeiros
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

5.  Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa.

Authors:  T Naas; L Poirel; A Karim; P Nordmann
Journal:  FEMS Microbiol Lett       Date:  1999-07-15       Impact factor: 2.742

6.  GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.

Authors:  L Poirel; G F Weldhagen; T Naas; C De Champs; M G Dove; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Characterization of multiple-antibiotic-resistant Salmonella typhimurium stains: molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone.

Authors:  H Vahaboglu; S Dodanli; C Eroglu; R Oztürk; G Soyletir; I Yildirim; V Avkan
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serine-beta-lactamase and VIM-2 metallo-beta-lactamase.

Authors:  J D Docquier; F Luzzaro; G Amicosante; A Toniolo; G M Rossolini
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

9.  TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.

Authors:  G C Paul; G Gerbaud; A Bure; A M Philippon; B Pangon; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait.

Authors:  L Poirel; V O Rotimi; E M Mokaddas; A Karim; P Nordmann
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883
View more
  61 in total

1.  Rapid detection and sequence-specific differentiation of extended-spectrum beta-lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assay.

Authors:  Gerhard F Weldhagen
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina.

Authors:  Fernando Pasteran; Diego Faccone; Alejandro Petroni; Melina Rapoport; Marcelo Galas; Miryam Vázquez; Adriana Procopio
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.

Authors:  Jacob Schlesinger; Shiri Navon-Venezia; Inna Chmelnitsky; Orly Hammer-Münz; Azita Leavitt; Howard S Gold; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  Emergence and dissemination of BEL-1-producing Pseudomonas aeruginosa isolates in Belgium.

Authors:  Pierre Bogaerts; Caroline Bauraing; A Deplano; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

6.  Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

Authors:  Renata Cristina Picão; Laurent Poirel; Ana C Gales; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

7.  Strain-tailored double-disk synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa.

Authors:  Didier Hocquet; Barbara Dehecq; Xavier Bertrand; Patrick Plésiat
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

8.  Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation.

Authors:  B Henrichfreise; I Wiegand; W Pfister; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

9.  Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India.

Authors:  Daniel Aubert; Delphine Girlich; Thierry Naas; Shanta Nagarajan; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Sequence-selective recognition of extended-spectrum beta-lactamase GES-2 by a competitive, peptide nucleic acid-based multiplex PCR assay.

Authors:  Gerhard F Weldhagen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.